Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (661-670 of 903) with videos related to

Pageof 91
Sort By:
Neurology|August 20, 2021
Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal AssociationsWillem S Eikelboom, Esther van den Berg, Ellen H Singleton, et al.
Brain : a Journal of Neurology|June 6, 2023
Tau protein spreads through functionally connected neurons in Alzheimer's disease: a combined MEG/PET studyDeborah N Schoonhoven, Emma M Coomans, Ana P Millán, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 2, 2022
Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trialAgnetha D Fruijtier, Jetske van der Schaar, Ingrid S van Maurik, et al.
Neurobiology of Aging|October 14, 2018
Repeat length variations in ATXN1 and AR modify disease expression in Alzheimer's diseaseSarah L Gardiner, Aster V E Harder, Yvonne J M Campman, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 14, 2020
Prediction of poor clinical outcome in vascular cognitive impairment: TRACE-VCI studyJooske M F Boomsma, Lieza G Exalto, Frederik Barkhof, et al.
Neurobiology of Aging|July 31, 2012
Microglial activation in Alzheimer's disease: an (R)-[¹¹C]PK11195 positron emission tomography studyAlie Schuitemaker, Marc A Kropholler, Ronald Boellaard, et al.
Neurology|July 18, 2020
Latent atrophy factors related to phenotypical variants of posterior cortical atrophyColin Groot, B T Thomas Yeo, Jacob W Vogel, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Point of view: Challenges in implementation of new immunotherapies for Alzheimer's diseaseSandar Aye, Gunilla Johansson, Christoph Hock, et al.
Neurology|February 3, 2022
Association of CSF, Plasma, and Imaging Markers of Neurodegeneration With Clinical Progression in People With Subjective Cognitive DeclineJarith L Ebenau, Wiesje Pelkmans, Inge M W Verberk, et al.
Plos One|January 16, 2020
Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracyHanneke F M Rhodius-Meester, Ingrid S van Maurik, Juha Koikkalainen, et al.
Pageof 91

Showing results (661-670 of 903) with videos related to

Sort By:
Pageof 91
Neurology|August 20, 2021
Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal AssociationsWillem S Eikelboom, Esther van den Berg, Ellen H Singleton, et al.
Brain : a Journal of Neurology|June 6, 2023
Tau protein spreads through functionally connected neurons in Alzheimer's disease: a combined MEG/PET studyDeborah N Schoonhoven, Emma M Coomans, Ana P Millán, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 2, 2022
Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trialAgnetha D Fruijtier, Jetske van der Schaar, Ingrid S van Maurik, et al.
Neurobiology of Aging|October 14, 2018
Repeat length variations in ATXN1 and AR modify disease expression in Alzheimer's diseaseSarah L Gardiner, Aster V E Harder, Yvonne J M Campman, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 14, 2020
Prediction of poor clinical outcome in vascular cognitive impairment: TRACE-VCI studyJooske M F Boomsma, Lieza G Exalto, Frederik Barkhof, et al.
Neurobiology of Aging|July 31, 2012
Microglial activation in Alzheimer's disease: an (R)-[¹¹C]PK11195 positron emission tomography studyAlie Schuitemaker, Marc A Kropholler, Ronald Boellaard, et al.
Neurology|July 18, 2020
Latent atrophy factors related to phenotypical variants of posterior cortical atrophyColin Groot, B T Thomas Yeo, Jacob W Vogel, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Point of view: Challenges in implementation of new immunotherapies for Alzheimer's diseaseSandar Aye, Gunilla Johansson, Christoph Hock, et al.
Neurology|February 3, 2022
Association of CSF, Plasma, and Imaging Markers of Neurodegeneration With Clinical Progression in People With Subjective Cognitive DeclineJarith L Ebenau, Wiesje Pelkmans, Inge M W Verberk, et al.
Plos One|January 16, 2020
Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracyHanneke F M Rhodius-Meester, Ingrid S van Maurik, Juha Koikkalainen, et al.
Pageof 91